Prostate Cancer Survey

Identifying Patient-relevant Adverse Events Following Prostate Radiotherapy

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03128710

Enrollment

224

Registered

2017-04-25

Start date

2017-03-15

Completion date

2018-02-15

Last updated

2024-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

Survey, Focus Group, Treatment Preferences

Brief summary

There have been calls from patients, payers, healthcare providers, and policy makers for an evaluation of newer, high-cost radiation technologies compared to conventional forms of radiation therapy. National attention has focused on the use of intensity modulated radiation therapy (IMRT) into routine daily clinical practice for prostate cancer. The goal of the present study is to determine whether the type of radiation treatment received by the patients can result in a reduction in patient-relevant side effects following prostate irradiation. The analysis will be performed by obtaining patient answered surveys looking at side effects.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

MALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Participant is 18 years or older * Has been diagnosed with prostate cancer * Able to speak and read English

Exclusion criteria

* Participant is not being seen for prostate cancer * Under the age of 18

Design outcomes

Primary

Measure	Time frame	Description
To determine patient preference weights for side effect reduction in radiation treatment of prostate cancer	3 years	Investigators will use an anonymous survey and results from multiple focus groups to quantify the relative importance/significance of commonly encountered side effects experienced by patients following external beam radiation therapy. We will complete descriptive statistics as a means of understanding the data obtained by survey responses. Additionally, comparative analyses may be undertaken to evaluate differences between different side effects experienced.

Countries

United States

Outcome results